SELENOP and retinopathy of prematurity: A post hoc analysis of the study revealed a statistical power of 96.3%, 97.6%, and 45% for the association between the SELENOP rs3877899AA genotype and the incidence of ROP requiring treatment, ROP treatment failure, and ELGA, respectively.